1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 144 F.Supp.2d
  5. 144 F.Supp.2d 21 (2000)
 

BRISTOL-MYERS SQUIBB CO. v. COPLEY PHARMACEUTICAL

No. Civ.A. 99-12434-JLT.

144 F.Supp.2d 21 (2000)

BRISTOL-MYERS SQUIBB CO., Plaintiff, v. COPLEY PHARMACEUTICAL, INC., Defendant.

United States District Court, D. Massachusetts.

December 29, 2000.

Attorney(s) appearing for the Case

Thomas J. Sartory, Goulston & Storrs, Boston, MA, Robert L. Baechtold, Joseph M. O'Malley, Jr., Fitzpatrick, Cella, Harper & Scinto, New York City, for Bristol-Myers Squibb Company, Plaintiff.

Daniel J. Gleason, Carl M. DeFranco, Jr., Nutter, McClennen & Fish, Boston, MA, for Copley Pharmaceutical, Inc., Defendant.

Daniel J. Gleason, Carl M. DeFranco, Jr., Nutter, McClennen & Fish, Boston, MA, for Copley Pharmaceutical, Inc., Counter-Claimant.

Thomas J. Sartory, Goulston & Storrs, Boston, MA, for Bristol-Myers Squibb Company, Counter-Defendant.

MEMORANDUM

TAURO, District Judge.

BACKGROUND

Plaintiff Bristol-Myers Squibb Co. ("Bristol"), a pharmaceuticals manufacturer, owns and received FDA approval for the "732 Patent," a patent for the stable flocculated suspension of megestrol acetate in water. In October 1999, Defendant Copley Pharmaceuticals, Inc. ("Copley"), a generic-drug manufacturer, filed with the FDA an Abbreviated New Drug Application ("ANDA") for approval of a...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases